本页面由Tiger Trade Technology Pte. Ltd.提供服务

Eterna Therapeutics Inc.

1.36
-0.2700-16.56%
盘后:1.360.00000.00%19:51 EST
成交量:2.04万
成交额:2.95万
市值:230.19万
市盈率:-0.08
高:1.60
开:1.60
低:1.35
收:1.63
52周最高:37.50
52周最低:1.35
股本:169.26万
流通股本:127.79万
量比:1.00
换手率:1.60%
股息:- -
股息率:- -
每股收益(TTM):-16.8048
每股收益(LYR):-55.8903
净资产收益率:-352.43%
总资产收益率:-120.56%
市净率:0.53
市盈率(LYR):-0.02

数据加载中...

2024/03/14

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/16

重要事件披露

Form 8-K - Current report
2024/01/31

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/20

重要事件披露

Form 8-K - Current report
2024/01/19

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

SEC问询函

Form CORRESP - Correspondence
2024/01/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/12/23

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/12/21

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/20

重要事件披露

Form 8-K - Current report
2023/12/15

重要事件披露

Form 8-K - Current report
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/01

重要事件披露

Form 8-K - Current report
2023/10/05

重要事件披露

Form 8-K - Current report
2023/09/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/09/08

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/09/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/29

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals